Published in Proc Natl Acad Sci U S A on August 15, 1995
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96
Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest (1997) 2.93
Death begets failure in the heart. J Clin Invest (2005) 2.72
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest (1999) 2.55
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest (1997) 2.31
Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest (1996) 2.21
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol (2002) 1.97
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest (2000) 1.90
Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol (2008) 1.85
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol (1997) 1.52
What do we know about the cardiac benefits of exercise? Trends Cardiovasc Med (2014) 1.45
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med (2017) 1.44
Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J Mol Cell Cardiol (2010) 1.24
Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res (2007) 1.16
Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart. Circ Res (2007) 1.13
Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrogenesis Tissue Repair (2012) 1.12
Morphological aspects of apoptosis in heart diseases. J Cell Mol Med (2006) 1.09
IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol Med (2009) 1.08
Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes. Exp Biol Med (Maywood) (2004) 1.00
Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis. Clin Transl Sci (2008) 1.00
Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol (1999) 0.95
Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev (2008) 0.94
Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy. J Biol Chem (2012) 0.92
Improved function of the failing rat heart by regulated expression of insulin-like growth factor I via intramuscular gene transfer. Hum Gene Ther (2012) 0.90
Mitochondrial Akt-regulated mitochondrial apoptosis signaling in cardiac muscle cells. Am J Physiol Heart Circ Physiol (2011) 0.89
Peroxisome proliferator-activated receptor (PPAR) gene profiling uncovers insulin-like growth factor-1 as a PPARalpha target gene in cardioprotection. J Biol Chem (2011) 0.87
Signalling between microvascular endothelium and cardiomyocytes through neuregulin. Cardiovasc Res (2014) 0.87
Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol (2012) 0.85
Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy. Vascul Pharmacol (2009) 0.85
Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart (2001) 0.84
GH and the cardiovascular system: an update on a topic at heart. Endocrine (2014) 0.84
The GH/IGF-1 Axis and Heart Failure. Curr Cardiol Rev (2009) 0.84
Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair. Int J Cardiol (2015) 0.82
Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. Biochem J (2001) 0.81
Insulin-like growth factor-1 in myocardial tissue: interaction with tumor necrosis factor. Crit Care (2003) 0.79
Apoptosis in dilated cardiomyopathy. Korean J Intern Med (2000) 0.79
Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in rats. Vasc Cell (2011) 0.78
Biomimetic scaffold combined with electrical stimulation and growth factor promotes tissue engineered cardiac development. Exp Cell Res (2013) 0.78
Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Eur J Nucl Med Mol Imaging (2003) 0.78
Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury. Br J Pharmacol (2008) 0.77
Combination of IGF‑1 gene manipulation and 5‑AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte‑like cells. Mol Med Rep (2014) 0.77
Influence of vascular endothelial growth factor stimulation and serum deprivation on gene activation patterns of human adipose tissue-derived stromal cells. Stem Cell Res Ther (2015) 0.77
Peripheral venous occlusion causing cardiac hypertrophy and changes in biological parameters in rats. Eur J Appl Physiol (2009) 0.76
Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth? Clin Med Insights Endocrinol Diabetes (2016) 0.76
Humanin: Functional Interfaces with IGF-I. Growth Horm IGF Res (2016) 0.76
PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice. J Pharmacol Exp Ther (2017) 0.75
Evaluating the association between insulin-like growth factor-1 values and short-term survival rates following acute myocardial infarction. Clin Med Insights Cardiol (2011) 0.75
Caffeoylquinic Acid Derivatives Extract of Erigeron multiradiatus Alleviated Acute Myocardial Ischemia Reperfusion Injury in Rats through Inhibiting NF-KappaB and JNK Activations. Mediators Inflamm (2016) 0.75
Mechanisms of oxidative stress and myocardial protection during open-heart surgery. Ann Card Anaesth (2015) 0.75
Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats. Int J Mol Sci (2011) 0.75
Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury. Mol Med Rep (2016) 0.75
Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell (1991) 13.70
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol (1982) 10.99
Social controls on cell survival and cell death. Nature (1992) 9.81
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med (1967) 6.12
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
Cell death and control of cell survival in the oligodendrocyte lineage. Cell (1992) 4.70
Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest (1994) 4.28
Actions of insulin-like growth factors. Annu Rev Physiol (1985) 3.80
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J (1994) 3.58
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07
Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res (1970) 2.02
NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med (1992) 1.95
Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation (1993) 1.86
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Mediation of cardioprotection by transforming growth factor-beta. Science (1990) 1.52
The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res (1992) 1.48
Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol (1993) 1.44
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int (1994) 1.35
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun (1991) 1.29
Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol (1994) 1.21
Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol (1993) 1.16
Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res (1994) 1.09
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol (1992) 1.01
Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int (1991) 0.98
Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther (1993) 0.96
Cytokines and growth factors in endothelial dysfunction. Crit Care Med (1993) 0.94
Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. Arterioscler Thromb (1994) 0.83
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury. J Pharmacol Exp Ther (1994) 0.82
Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. Am J Physiol (1994) 0.80
rhIGF-I enhances functional recovery from sciatic crush. Time-course and dose-response study. Ann N Y Acad Sci (1993) 0.79
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 4.01
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation (2001) 3.50
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail (2010) 2.30
Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08
Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07
Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation (2001) 1.92
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80
Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation (1997) 1.66
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol (1998) 1.61
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48
Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47
Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47
Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat. Circ Res (1974) 1.40
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A (1997) 1.38
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol (1997) 1.37
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med (1991) 1.33
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Presence of a myocardial depressant factor in patients in circulatory shock. Surgery (1971) 1.28
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26
Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation (2000) 1.25
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24
Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood (1998) 1.23
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab (2001) 1.23
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22
Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol (1994) 1.21
Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol (1989) 1.21
Blood-borne humoral factors in the pathophysiology of circulatory shock. Circ Res (1973) 1.18
Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol (1995) 1.16
Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol (1998) 1.15
Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation (1993) 1.13
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13
Studies on extracellular matrix components that promote neurite outgrowth. Cold Spring Harb Symp Quant Biol (1983) 1.12
Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 1.12
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med (Berl) (2006) 1.12
Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc (1971) 1.11
Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol (1989) 1.11
Antibodies which antagonise the effects of prostacyclin. Nature (1978) 1.10
Origin of myocardial depressant factor in shock. Am J Physiol (1970) 1.09
Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol (1995) 1.08
Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery (1971) 1.08
Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia (2009) 1.08
Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol (1999) 1.08
Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol (2001) 1.05
C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J (2000) 1.05
Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats. Circ Res (1970) 1.05
Direct measurement of nitric oxide release from vascular endothelial cells. J Appl Physiol (1985) (1996) 1.05
Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation (1997) 1.04
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther (1988) 1.04
Pathophysiological mechanisms of sudden death induced by platelet activating factor. Br J Pharmacol (1984) 1.04
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med (1999) 1.03
Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation (1997) 1.03
Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol (1983) 1.03
Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol (1996) 1.02
Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res (1996) 1.02
Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol (2000) 1.02
Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res (1994) 1.02
Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol (1980) 1.02
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol (2000) 1.01
Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg (1997) 1.01
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol (1992) 1.01
Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Science (1986) 1.01
Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes (2012) 1.01
Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats. Circ Res (1970) 1.00
Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol (1990) 1.00
Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res (1999) 0.99
Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res (1980) 0.98
Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol (1978) 0.98
Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J Mol Cell Cardiol (1996) 0.98
Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Proc Soc Exp Biol Med (1988) 0.97
Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol (2000) 0.97
Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res (1991) 0.97
HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J (2001) 0.96
Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock (1992) 0.96
Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol (1997) 0.96
Characterization of a myocardial depressant factor present in hemorrhagic shock. Am J Physiol (1967) 0.96
Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem Biophys Res Commun (1994) 0.96
Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol (2002) 0.96
Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen Pharmacol (1999) 0.96
Leukotrienes as mediators of ischemia and shock. Biochem Pharmacol (1986) 0.96
Plasma activation during splanchnic arterial occlusion shock. Shock (2000) 0.95
Eicosanoids as mediators of ischemia and shock. Fed Proc (1985) 0.95